CGEM
Cullinan Therapeutics, Inc.Company with tickers: CGEM
CIK
1789972
CUSIP
230031106
Shares Outstanding
60,526,128
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-05 | Michaelson Jennifer | Chief Scientific Officer | Convert | 4,000 |
| 2026-03-05 | Michaelson Jennifer | Chief Scientific Officer | Sell | 8,000 |
| 2026-03-05 | Michaelson Jennifer | Chief Scientific Officer | Convert | 4,000 |
| 2026-02-25 | Michaelson Jennifer | Chief Scientific Officer | Sell | 1,780 |
| 2026-02-24 | Michaelson Jennifer | Chief Scientific Officer | Sell | 3,601 |
| 2026-02-24 | AHMED NADIM | EVP and President, Hematology | Sell | 13,515 |
| 2026-02-24 | Jones Jeffrey Alan | Chief Medical Officer | Sell | 4,582 |
| 2026-02-24 | SUMER JACQUELYN L | Chief Legal Officer | Sell | 3,601 |
| 2026-02-23 | Michaelson Jennifer | Chief Scientific Officer | Sell | 1,752 |
| 2026-02-20 | Jones Jeffrey Alan | Chief Medical Officer | Sell | 4,982 |
| 2026-02-20 | AHMED NADIM | EVP and President, Hematology | Sell | 16,381 |
| 2026-02-20 | Michaelson Jennifer | Chief Scientific Officer | Sell | 3,742 |
| 2026-02-20 | Michaelson Jennifer | Chief Scientific Officer | Convert | 8,000 |
| 2026-02-20 | Michaelson Jennifer | Chief Scientific Officer | Convert | 8,000 |
| 2026-02-20 | SUMER JACQUELYN L | Chief Legal Officer | Sell | 3,742 |
| 2026-02-20 | Fenton Mary Kay | Chief Financial Officer | Sell | 4,398 |
| 2026-02-18 | Jones Jeffrey Alan | Chief Medical Officer | Award | 300,000 |
| 2026-02-18 | Michaelson Jennifer | Chief Scientific Officer | Award | 57,500 |
| 2026-02-18 | Michaelson Jennifer | Chief Scientific Officer | Award | 115,000 |
| 2026-02-18 | SUMER JACQUELYN L | Chief Legal Officer | Award | 230,000 |
| 2026-02-18 | AHMED NADIM | EVP and President, Hematology | Award | 828,000 |
| 2026-02-18 | Savill Corrine | Chief Business Officer | Award | 175,000 |
| 2026-02-18 | Fenton Mary Kay | Chief Financial Officer | Award | 137,500 |
| 2026-02-18 | Fenton Mary Kay | Chief Financial Officer | Award | 68,750 |
| 2026-02-12 | Michaelson Jennifer | Chief Scientific Officer | Sell | 416 |
| 2026-01-22 | Michaelson Jennifer | Chief Scientific Officer | Sell | 4,000 |
| 2025-12-31 | Fenton Mary Kay | Chief Financial Officer | Award | 27 |
| 2025-12-23 | AHMED NADIM | EVP and President, Hematology | Sell | 9,922 |
| 2025-12-19 | Michaelson Jennifer | Chief Scientific Officer | Sell | 1,345 |
| 2025-12-18 | SUMER JACQUELYN L | Chief Legal Officer | Sell | 3,480 |
| 2025-12-18 | Jones Jeffrey Alan | Chief Medical Officer | Sell | 4,632 |
| 2025-12-18 | Michaelson Jennifer | Chief Scientific Officer | Sell | 2,898 |
| 2025-12-15 | Michaelson Jennifer | Chief Scientific Officer | Sell | 995 |
| 2025-12-12 | Michaelson Jennifer | Chief Scientific Officer | Sell | 2,148 |
| 2025-11-24 | Michaelson Jennifer | Chief Scientific Officer | Sell | 4,000 |
| 2025-10-28 | Lynx1 Capital Management LP | 10% Owner | Buy | 165,667 |
| 2025-10-17 | Lynx1 Capital Management LP | 10% Owner | Buy | 32,217 |
| 2025-10-16 | Lynx1 Capital Management LP | 10% Owner | Buy | 150,000 |
| 2025-10-15 | Lynx1 Capital Management LP | 10% Owner | Buy | 51,500 |
| 2025-10-14 | Lynx1 Capital Management LP | 10% Owner | Buy | 15,032 |
| 2025-10-10 | Lynx1 Capital Management LP | 10% Owner | Buy | 277,298 |
| 2025-10-09 | Lynx1 Capital Management LP | 10% Owner | Buy | 626,043 |
| 2025-10-08 | Lynx1 Capital Management LP | 10% Owner | Buy | 556,300 |
| 2025-10-08 | Lynx1 Capital Management LP | 10% Owner | Other | 7,089,443 |
| 2025-08-07 | Doyle Mittie | Director | Award | 79,456 |
| 2025-08-07 | Allen Andrew R | Director | Award | 79,456 |
| 2025-08-07 | Doyle Mittie | Director | Other | 0 |
| 2025-08-07 | Allen Andrew R | Director | Other | 0 |
| 2025-06-12 | Webster Stephen W | Director | Award | 38,513 |
| 2025-06-12 | Meek David D. | Director | Award | 38,513 |
| 2025-06-12 | Martin Anne-Marie | Director | Award | 38,513 |
| 2025-06-12 | Ryan David P. | Director | Award | 38,513 |
| 2025-06-12 | Rosenberg Anthony | Director | Award | 38,513 |
| 2025-02-25 | AHMED NADIM | EVP and President, Hematology | Sell | 12,529 |
| 2025-02-25 | SUMER JACQUELYN L | Chief Legal Officer | Sell | 3,756 |
| 2025-02-25 | Jones Jeffrey Alan | Chief Medical Officer | Sell | 4,895 |
| 2025-02-25 | Michaelson Jennifer | Chief Scientific Officer | Sell | 3,756 |
| 2025-02-19 | Savill Corrine | Chief Business Officer | Award | 37,500 |
| 2025-02-19 | Savill Corrine | Chief Business Officer | Award | 75,000 |
| 2025-02-19 | Michaelson Jennifer | Chief Scientific Officer | Award | 100,000 |
| 2025-02-19 | Michaelson Jennifer | Chief Scientific Officer | Award | 50,000 |
| 2025-02-19 | SUMER JACQUELYN L | Chief Legal Officer | Award | 50,000 |
| 2025-02-19 | SUMER JACQUELYN L | Chief Legal Officer | Award | 100,000 |
| 2025-02-19 | AHMED NADIM | EVP and President, Hematology | Award | 180,000 |
| 2025-02-19 | AHMED NADIM | EVP and President, Hematology | Award | 360,000 |
| 2025-02-19 | Jones Jeffrey Alan | Chief Medical Officer | Award | 130,000 |
| 2025-02-19 | Jones Jeffrey Alan | Chief Medical Officer | Award | 65,000 |
| 2025-02-19 | Fenton Mary Kay | Chief Financial Officer | Award | 60,000 |
| 2025-02-19 | Fenton Mary Kay | Chief Financial Officer | Award | 120,000 |
| 2025-01-06 | Michaelson Jennifer | Chief Scientific Officer | Sell | 4,000 |
| 2024-12-24 | AHMED NADIM | EVP and President, Hematology | Sell | 8,400 |
| 2024-12-18 | Jones Jeffrey Alan | Chief Medical Officer | Sell | 4,632 |
| 2024-12-18 | Michaelson Jennifer | Chief Scientific Officer | Sell | 4,693 |
| 2024-12-18 | SUMER JACQUELYN L | Chief Legal Officer | Sell | 3,482 |
| 2024-12-12 | Michaelson Jennifer | Chief Scientific Officer | Sell | 3,489 |
| 2024-11-05 | Michaelson Jennifer | Chief Scientific Officer | Sell | 8,000 |
| 2024-09-05 | Michaelson Jennifer | Chief Scientific Officer | Sell | 8,000 |
| 2024-08-08 | Thistle Mary | Director | Award | 25,743 |
| 2024-08-08 | Thistle Mary | Director | Other | 0 |
| 2024-07-05 | Michaelson Jennifer | Chief Scientific Officer | Sell | 8,000 |
| 2024-07-01 | Michaelson Jennifer | Chief Scientific Officer | Award | 2,360 |
| 2024-06-26 | Ryan David P. | Director | Award | 15,806 |
| 2024-06-26 | Rosenberg Anthony | Director | Award | 15,806 |
| 2024-06-26 | Webster Stephen W | Director | Award | 15,806 |
| 2024-06-26 | Martin Anne-Marie | Director | Award | 15,806 |
| 2024-06-10 | Ebeling Thomas | Director | Convert | 18,450 |
| 2024-06-10 | Ebeling Thomas | Director | Convert | 18,450 |
| 2024-05-23 | Ebeling Thomas | Director | Convert | 84,224 |
| 2024-05-23 | Ebeling Thomas | Director | Award | 84,224 |
| 2024-05-15 | Meek David D. | Director | Award | 15,618 |
| 2024-05-15 | Meek David D. | Director | Other | 0 |
| 2024-05-07 | Michaelson Jennifer | Chief Scientific Officer | Convert | 5,606 |
| 2024-05-07 | Michaelson Jennifer | Chief Scientific Officer | Sell | 5,606 |
| 2024-05-07 | Michaelson Jennifer | Chief Scientific Officer | Convert | 5,606 |
| 2024-05-06 | Michaelson Jennifer | Chief Scientific Officer | Sell | 37,723 |
| 2024-05-06 | Michaelson Jennifer | Chief Scientific Officer | Convert | 50,000 |
| 2024-05-06 | Michaelson Jennifer | Chief Scientific Officer | Convert | 50,000 |
| 2024-04-29 | Fenton Mary Kay | Chief Financial Officer | Award | 200,000 |
| 2024-04-29 | Fenton Mary Kay | Chief Financial Officer | Other | 0 |
| 2024-03-29 | Nguyen Nate | Interim PAO and PFO | Other | 0 |